Skip to main content
Veterinary Medicines

Equipalazone 1 g Oral powder

Authorised
  • Phenylbutazone

Product identification

Medicine name:
Fenylbutazon Dechra Vet 1 g pulver til hest og ponni
Equipalazone 1 g Oral powder
Active substance:
  • Phenylbutazone
Target species:
  • Horse (pony)
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenylbutazone
    1.00
    gram(s)
    /
    1.00
    Sachet
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • Oral use
    • Horse (pony)
      • Meat and offal
        no withdrawal period
    • Horse
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AA01
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Equipalazone 1 g or. pwdr. sachet 100
  • Equipalazone 1 g or. pwdr. sachet 32

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 16-11233
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0037/001
Concerned member states:
  • Austria
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 20/11/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 20/11/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."